Evidence map›Paper›PMID 34826016›Full record

ArticleInternational journal of clinical pharmacy2022

The role of community pharmacists in immunisation: a national cross-sectional study.

Nikolaus Lindner, Martin Riesenhuber, Thomas Müller-Uri, Anita Elaine Weidmann

Open access · hybridAbstract read
In one paragraph

Article in International journal of clinical pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Nikolaus LindnerSchool of Pharmacy and Life Sciences, Robert Gordon University, Garthdee Road, Aberdeen, AB10 7QB, Scotland, UK. lindnerniko@gmail.com.ORCID http://orcid.org/0000-0001-5123-2280
Martin RiesenhuberDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-5061-7354
Thomas Müller-UriVindobona-Apotheke, Community Pharmacy, Vienna, Austria.
Anita Elaine WeidmannFaculty of Chemistry and Pharmacy, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0003-3670-2357
Medical University of Vienna · ATRobert Gordon University · GBUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Austrian pharmacists are not authorised to administer immunisations, and evidence about their willingness to immunise is lacking. Aim The aim of this study is to investigate Austrian community pharmacists' willingness to administer immunisations in the future. Method This study is designed as a cross-sectional online survey based on the theoretical domains framework (TDF). The validated and piloted questionnaire obtained ethical approval by Robert Gordon University. Outcome measures included pharmacists' willingness to immunise, service requirements, barriers and education needs. Results The questionnaire was sent out to 3086 community pharmacists of which 380 responses were included in the final analysis (12.3%). Willingness to administer immunisations after appropriate training and legislative regulation was stated by 82.6% (n = 314) of participants. It was demonstrated that pharmacists willing to immunise were significantly younger than their counterpart (38 [IQR 31-49] years vs. 45 [IQR 37.5-54] years; OR 1.06; 1.03-1.09, 95% CI; p < 0.001). 'Legal liability' was considered the most critical barrier to service implementation, 'seeing blood' and 'close patient contact' as least critical. Pharmacists not willing to immunise showed a higher probability to evaluate personnel resources (OR 2.98; 1.35-6.58, 95% CI; p = 0.007), close patient contact (OR 2.79; 1.46-5.34, 95% CI; p = 0.002) and management of side effects (OR 2.62; 1.21-5.67, 95% CI; p = 0.015) as (highly) critical. The majority assessed the 'right timing for training' to be after the foundation training with a 2-yearly renewal. Conclusion Austrian community pharmacists show a strong willingness to administer immunisations while highlighting important requirements and barriers towards service implementation.

Indexed as

Community Pharmacy ServicesPharmacistsAttitude of Health PersonnelCross-Sectional StudiesHumansImmunizationProfessional RoleSurveys and QuestionnairesCommunity pharmacyCovidPharmacist immunisationQuestionnaireService implementationSurveyVaccine

Identifiers

PMID34826016
PMCPMC8622494
OpenAlexW3217212844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.